Form 4: NeueHealth Director Makhzoumi Reports Stock Transactions and RSU Vesting

Director Mohamad Makhzoumi reports acquisition of shares through RSU vesting and adjustments to beneficial ownership following a reverse stock split.

Summary

• On May 12, 2024, Director Mohamad Makhzoumi reported transactions involving NeueHealth, Inc. common stock.
• These transactions include the vesting of 4,755 restricted stock units (RSUs) which converted into common stock.
• Additionally, Makhzoumi acquired 10,500 restricted stock units on May 13, 2024, which will vest on May 13, 2025.
• The report also reflects adjustments due to a 1-for-80 reverse stock split that occurred on May 22, 2023.
• Makhzoumi disclaims beneficial ownership of shares held by NEA 15, NEA 15-OF, NEA 16, and NEA 17, where he serves as a manager of the general partners, due to no direct pecuniary interest.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing detailing stock transactions. The sentiment is neutral as it primarily reports facts without expressing opinions or forward-looking statements that would significantly impact investor sentiment.

Positives

• The vesting of RSUs indicates a potential alignment of the director's interests with the company's performance.
• The acquisition of additional RSUs suggests continued confidence in the company's future prospects.

Future Outlook

The director will receive shares of common stock in the future as the newly granted RSUs vest on May 13, 2025.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• Shareholders can monitor insider transactions to assess management's alignment with company performance.

Key Dates